Concentrix Corporation

03/27/2026 | Press release | Distributed by Public on 03/27/2026 05:35

Proxy Results, Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As described below in Item 5.07 of this Current Report on Form 8-K, on March 25, 2026, the stockholders of Concentrix Corporation (the "Company") approved an amendment (the "Amendment") to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan, as amended (the "2020 Plan"), at the Company's 2026 Annual Meeting of Stockholders (the "Annual Meeting") to increase the number of shares available for issuance thereunder by 3,700,000 shares. The Amendment was previously approved by the Company's Board of Directors.
The foregoing summary is qualified in its entirety by reference to the full text of the Amendment, a copy of which is filed as Exhibit 10.1 to this Form 8-K and is incorporated herein by reference.
Item 5.07. Submission of Matters to a Vote of Security Holders.
On March 25, 2026, the Company held the Annual Meeting for which the Company's Board of Directors solicited proxies pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended.
At the Annual Meeting, the Company's stockholders (1) elected nine directors to serve on the Company's Board of Directors, (2) ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2026, (3) approved, on an advisory basis, the compensation of the Company's named executive officers, and (4) approved an amendment to the 2020 Plan to increase the number of shares available for issuance thereunder.
Set forth below are the final voting results for these proposals, each of which were described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on February 13, 2026:
1.The election of nine directors to serve on the Company's Board of Directors for terms expiring at the Company's 2027 Annual Meeting of Stockholders.
Nominee
For
Withhold
Broker Non-Votes
Christopher Caldwell
51,981,955
331,206
4,290,089
Chih-Kai Cheng
51,618,330
694,831
4,290,089
LaVerne H. Council
51,866,198
446,963
4,290,089
Jennifer Deason
51,875,444
437,717
4,290,089
Kathryn Hayley
51,525,159
788,002
4,290,089
Kathryn Marinello
52,018,925
294,236
4,290,089
Bilge Ogut
52,102,002
211,159
4,290,089
Dennis Polk
52,018,323
294,838
4,290,089
Ann Vezina
51,872,208
440,953
4,290,089
2.The ratification of the appointment of Ernst & Young LLP as the Company's independent registered accounting firm for fiscal year 2026.
For
Against
Abstain
Broker Non-Votes
56,049,937
453,129
100,184
-
3.The approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's proxy statement.
For
Against
Abstain
Broker Non-Votes
50,867,486
1,372,520
73,155
4,290,089
4.The approval of an amendment to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan, as amended, to increase the number of shares available for issuance thereunder.
For
Against
Abstain
Broker Non-Votes
36,462,977
15,803,365
46,819
4,290,089
.
Concentrix Corporation published this content on March 27, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 27, 2026 at 11:35 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]